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Background: Wall stress is a useful concept to understand the progression of ventricular remodeling. We measured
cumulative LV wall stress throughout the cardiac cycle over unit time and tested whether this “integrated wall
stress (IWS)” would provide a reliable marker of total ventricular workload.
Methods and results: We applied IWS to mice after experimental myocardial infarction (MI) and sham-operated
mice, both at rest and under dobutamine stimulation. Small infarcts were created so as not to cause subsequent
overt hemodynamic decompensation. IWS was calculated over one minute through simultaneous measurement of
LV internal diameter and wall thickness by echocardiography and LV pressure by LV catheterization. At rest, the MI
group showed concentric LV hypertrophy pattern with preserved LV cavity size, LV systolic function, and IWS
comparable with the sham group. Dobutamine stimulation induced a dose-dependent increase in IWS in MI mice,
but not in sham mice; MI mice mainly increased heart rate, whereas sham mice increased LV systolic and diastolic
function. IWS showed good correlation with a product of peak-systolic wall stress and heart rate. We postulate that
this increase in IWS in post-MI mice represents limited myocardial contractile reserve.
Conclusion: We hereby propose that IWS provides a useful estimate of total ventricular workload in the mouse
model and that increased IWS indicates limited LV myocardial contractile reserve.
Keywords: Wall stress, Ventricular workload, Myocardial contractile reserve, Ventricular remodelingIntroduction
Ventricular remodeling is a chronic progressive patho-
logical process that results in heart failure after myocardial
infarction (MI) or persistent unrelieved biomechanical
overload [1,2]. Persistent and unrelieved biomechanical
overload in combination with activation of inflammatory
mediators and neurohormones is thought to be responsible
for progressive ventricular remodeling after MI [3,4], but
studies to investigate specific mechanisms in animals are
hampered by the difficulty involved in quantifying bio-
mechanical workload in vivo. The magnitude of ventricular
remodeling advances in line with progressive ventricular
geometric changes including myocardial hypertrophy and* Correspondence: ttsuda@nemours.org
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reproduction in any medium, provided the orchamber dilatation with accompanying functional deterior-
ation [1,2]. Previously, we proposed that post-ischemic
ventricular remodeling is a pathological spectrum ranging
from benign myocardial hypertrophy to progressive heart
failure in the mouse model in which the prognosis is
primarily determined by the magnitude of residual
hemodynamic effects [5]. However, there has been no
optimum quantitative measurement of ventricular work-
load as a contributory indicator of ventricular remodeling
other than wall stress theory to explain how ventricular
dilatation and hypertrophy develop after loss of viable
working myocardium [6,7].
The concept of ventricular wall stress was introduced
by Strauer et al. as a primary determinant of myocardial
oxygen demand [8]. They indicated that overall myocar-
dial energy demand depends upon intramyocardial wall
tension, inotropic state of the myocardium, and heart
rate. Wall stress theory is commonly introduced to ex-
plain development of concentric hypertrophy in chronictd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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in the failing heart. One study argued that peak-systolic
wall stress increased as LV function worsened in a
chronic volume overloaded status [9], and another sug-
gested that peak-systolic wall stress closely reflected LV
functional reserve during exercise [10]. However, the ef-
fect of heart rate or myocardial contractility was not
considered in either study. Heart rate has been shown to
be one of several important factors contributing to myo-
cardial oxygen consumption [11].
Herein, we introduce a novel concept of “integrated
wall stress (IWS)” to assess its significance as a marker
of total ventricular workload and to validate its physio-
logical relevance in the mouse model. The concept of
continuous LV wall stress measurement was reported
previously, but authors did not address the overall ef-
fects of changing wall stress during the cardiac cycle on
the working myocardium [12]. We have defined IWS as
cumulative wall stress over unit time: IWS was obtained
by integrating continuous wall stress curve by accumu-
lating wall stress values at millisecond sampling intervals
over 1 min. By calculating IWS, we were able to incorpor-
ate the effects of not only systolic wall stress, but also of
heart rate and inotropic status of the myocardium. These
data were analyzed against conventional hemodynamic
parameters in animals with and without MI in conjunc-
tion with incremental dobutamine stress. We hypothesize
that unchanged IWS represents stable ventricular myo-
cardial contractile reserve and that increase in IWS
implies an early sign of mismatch between myocardial




A total of twenty (20) male C57BL/6 mice were used
according to an IACUC-approved protocol. Ten mice
were randomly assigned to an MI group and the other
10 to a sham group. The investigation conformed with
the Guide for the Care and Use of Laboratory Animals
published by the US National Institute of Health (NIH
Publication No. 85-23, revised 1996).
Experimental MI by coronary artery ligation
Experimental MI was induced as described by the au-
thors in detail elsewhere [5,13]. Briefly, under isoflurane
anesthesia (2%), the heart was exposed via small left
thoracotomy, and suture ligation was placed at the distal
one-third of the left anterior descending coronary artery
(LAD) with a 6.0 silk suture. With this procedure, ap-
proximately 35% of LV myocardium was subjected to
permanent ischemia, but only 14% became infarcted at
both 24 and 72 hours after MI [5]. Because of the rela-
tively small size of infarction, MI mice did not develophemodynamic deterioration but marked compensatory
LV hypertrophy in the non-ischemic myocardium 1 week
after MI [5]. For post-operative pain management,
meloxicam 5 mg/kg was given subcutaneously after the
experimental MI before transferring back to vivarium.
All mice survived for 7 wks after the procedure.
Echocardiography
Echocardiography was performed at baseline and weekly
after LAD ligation using a 30 MHz transducer (Vevo770,
VisualSonics, Toronto, Canada) under isoflurane anesthesia
(1.5%). Once the parasternal short-axis view of the LV was
established by B-mode, M-mode tracings were recorded to
measure left ventricular internal diameter in diastole
(LVIDd), left ventricular posterior wall thickness in
diastole (LVPWd), and left ventricular internal diam-
eter in systole (LVIDs). Calculated values are fractional
shortening (%FS) = {(LVIDd – LVIDs)/LVIDd} × 100, and the
mean velocity of circumferential fiber shortening (%Vcf) =
(LVIDd – LVIDs)/(LVIDd× ET) (ET: ejection time in sec).
Hemodynamic assessment with echocardiogram
Seven weeks after experimental MI, the mice were anes-
thetized with intraperitoneal injection of ketamine
(50 μg/g body weight) and xylazine (5 μg/g body
weight). A 1.4 Fr Millar Mikro-tip Catheter Transducer
(Model SPR-671, Millar Instruments, Houston, TX) was
inserted through right common carotid artery cutdown
into the LV cavity. The LV pressure signals were ported to
the Vevo770 Ultrasound System in real time. Simultan-
eously, M-mode echocardiogram was obtained from para-
sternal short axis view. LV systolic pressure (SP) and LV
end diastolic pressure (LVEDP) were measured. The max-
imum values of the first derivatives of the ascending (+)
and descending (−) left ventricular pressure [(+)dP/dTmax,
(−)dP/dTmax] were also obtained. LV pressure waveform
input and pressure derivative (dP/dT) were superimposed
on the electrocardiogram (ECG) trace in real time
along with data regarding heart rate (HR) and body
temperature (ºC).
Dobutamine stress test
A PE-10 catheter (Becton Dickinson, Mountain View, CA)
was inserted retrograde into the left jugular vein by cutdown
for dobutamine infusion at the time of hemodynamic evalu-
ation, as described elsewhere [14]. Dobutamine was infused
at the rate of 5 and 10 μg/kg/min with microinfusion pump
(KDS100, KD Scientific, Holliston, MA). Hemodynamic data
were obtained after 3 minutes of dobutamine infusion at the
specified rate.
Continuous wall stress (CWS) curve and IWS
CWS curves were obtained via the simultaneous measure-
ment of LVID and LVPW by M-mode echocardiogram
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LV wall stress (σ) was calculated as follows [12,15]:
sm ¼ PR2i = Ro−Rið Þ Ro þ Rið Þ½  ¼ PRi=2h 1þ h=2Rið Þ
P = Pressure, Ro =Outer diameter, Ri = Inner diameter
(LVID), h =Wall thickness (LVPW)Figure 1 Continuous wall stress measurement in the mouse model. A
obtaining continuous wall stress (CWS). The CWS curve was obtained from
1 msec. Blue line outlines LV endocardial surfaces (a and b) and epicardial
and LVP measurement, respectively. When calculating wall stress, LVID and
B: CWS curve obtained from the formula (see text) with dobutamine stim
mouse. IWS was calculated as an area below CWS curve over unit time.The IWS was calculated as an integration of continu-
ous wall stress over unit time (60 sec or 60,000 msec),
which was equivalent to the area under the continuous
wall stress curve.
IWS ¼ ∫σmdt. Simultaneous M-mode echocardiogram and LVP monitoring in
direct simultaneous measurement of LVID, LVPW, and LVP every
surface (c). Red line and green line indicate electrocardiogram (ECG)
LVPW were used as inner diameter and wall thickness, respectively.
ulation (baseline, 5, and 10 μg/kg/min) in the normal control
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remodeling
After hemodynamic and IWS measurements were com-
pleted, the animal was euthanized and the heart was
excised. The LV/body weight ratio was calculated as a
gross indicator of cardiac hypertrophy. Then, non-
infarct LV myocardium was collected for molecular
and histological examinations by obtaining the LV
myocardium proximal to the suture site. For histology,
the myocardial tissue was fixed in 10% formalin/PBS
and was embedded in paraffin. Hematoxylin and eosin
(H&E) staining and Masson’s trichrome staining were
performed to assess basic tissue architecture and de-
gree of myocardial fibrosis, respectively.
Real time reverse transcriptase polymerase chain reaction
(qRT-PCR)
Total RNA was extracted from non-infarct region of the
LV myocardium of MI hearts and the same anatomical re-
gion of sham hearts with TRIreagent (Applied Biosystems,
Foster City, CA). After DNAse treatment (RNase-Free
DNase Set, Qiagen Inc, Valencia, CA), mRNA was reverse-
transcribed to synthesize first-strand cDNA (iScript cDNA
Synthesis Kit, Bio-RAD Laboratories, Inc., Hercules, CA).
For PCR amplification, SYBR Green 1 kits (Bio-RAD La-
boratories) were used with validated primers (see Table 1).
PCR was carried out in a MyiQ Single-Color Real-Time
PCR Detection System (Bio-Rad Laboratories). Data were
recorded and analyzed using MyiQ software with glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH), which showed
consistent expression across all our samples, as an internal
control. The relative expression of each gene was deter-
mined as the cycle threshold (Ct) of the gene of interest
relative to GAPDH by the following formula:
ΔCt ¼ 2 Ct GAPDHð Þ− Ct gene of interestð Þ½ Table 1 The real-time RT-PCR primers used in this study





Col I GCG AGT GCT GTG CTT TCT G 68
TCC CTC GAC TCC TAC ATC TTC




Descriptive statistics were calculated. Two-tailed, paired
t-tests were used to compare the anatomical, hemodynamic,
and molecular data between MI and Sham groups. Compar-
isons of the temporal parameters (blood pressure and echo-
cardiographic data) of MI and sham hearts were performed
by one-way analysis of variance (ANOVA) followed by the
Student-Newman-Keuls post-hoc test to assess the signifi-
cance of data values (p < 0.05 considered significant). All
data are expressed as mean ± SEM unless otherwise noted.
Results
Measurement of CWS in the mouse model
The ages of mice were 7.80 ± 1.55 months old. Their
body weights ranged from 25 to 35 g (30.13 ± 3.19 g).
CWS was obtained via simultaneous measurement of LV
pressure (P), LVID (2Ri), and LVPW (h) (Figure 1A). WS
was calculated every 1 msec to generate an essentially
CWS curve, which appears quite similar to the curve
obtained in the human study [12] and in the canine model
[11]. With the incremental infusion of dobutamine, the
CWS curve of one of the sham operated mice shifted to
the left with decreased cycle length and increased peak
value (Figure 1B). IWS was calculated by integrating the
WS data over 60,000 samplings (= 1 min). IWS changes
with dobutamine infusion are shown later.
Gradual LV geometric changes after small MI
To assess the efficacy of IWS, we examined echocardio-
graphic and hemodynamic changes as well as IWS in
post-MI and sham-operated hearts. There was no mor-
tality following small MI throughout the 7 weeks of ob-
servation. Echocardiogram was obtained at 0, 1, 3, and
5 weeks after MI under isoflurane anesthesia to assess the
temporal changes in LV dilatation [LVID(d)], LV hyper-
trophy [LVPW(d)], and systolic performance (%FS and
%Vcf) in MI (n = 5) and sham (n = 5) groups (Figure 2A).
Progressive ventricular hypertrophy was seen in the MI
group as indicated by a continuous increase in LVPWd
after MI. The LV cavity size remained relatively unchanged
in both groups. This experimentally created small MI was
restricted to the LV apex [5], and echocardiogram revealed
that the majority of the LV appeared symmetrical, and LV
myocardium including LV free wall and interventricular
septum showed normal symmetric ventricular wall
motion without segmental hypokinesia or dyskinesia. LV
systolic performance presented by %FS and %Vcf was
comparable between the two groups. These results indi-
cate that the small MI procedure induced nearly concen-
tric LV hypertrophy without LV chamber dilatation. The
presence of ventricular hypertrophy in the MI group was
also confirmed by LV (mg)/body (g) weight ratio, which
was significantly higher than in the sham group (MI 5.11




































































Figure 2 Assessment of ventricular remodeling by echocardiography (A) and LVW/BW ratio. A. Echocardiographic parameters at 1, 3, and
5 weeks after MI (n = 5) and sham groups (n = 5) under isoflurane anesthesia. A progressive increase in LVPWd was seen in MI group compared with
sham, but there were no significant differences in LVIDd, %FS, or %Vcf between the two groups. * p < 0.05 vs. sham, # p < 0.05 vs. baseline. MI:
myocardial infarction, SH: sham. B. LVW/BW ratio (mg/g) was significantly higher in MI group (n = 5) than in sham group (n = 5) (MI: 5.11 ± 0.32,
sham 3.60 ± 0.35; p < 0.05), supporting the echocardiographic finding of LV hypertrophy in MI group. * p < 0.05 vs. sham.
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remodeling in the small MI model
This small MI model was previously reported by us as an
experimental model to induce ventricular remodeling with-
out initial hemodynamic deterioration [5]. After 7 weeks, asignificant increase in the mRNA of hypertrophic markers,
including ANP and BNP, was seen in the non-ischemic
hypertrophied myocardium of the MI group, when com-
pared with that of sham animals (Figure 3). In addition,
























Col I Col III
Figure 3 Molecular expression and histological changes in non-ischemic myocardium in sham and MI mice. Upper: The mRNA levels of
ANP, BNP, and collagens type I and III in the non-ischemic myocardium of MI (n = 5) and sham (n = 5) groups by real-time RT-PCR to assess the
molecular aspects of myocardial hypertrophy and fibrosis. ANP, BNP, and collagens type I and III were all significantly up-regulated in MI
myocardium compared with sham myocardium. * p < 0.05 vs. sham. Lower: Myocardial fibrosis in the remote non-ischemic myocardium after MI.
Histological assessment of remote non-ischemic myocardium with H&E (left column; A and C) and Masson’s Trichrome staining (right column; B
and D. Collagen stains as blue color) in sham (A, B) and MI (C, D) hearts. In MI hearts, there is an increase deposition of collagen in the interstitial
space (arrows) in the remote non-ischemic myocardium suggesting the development of myocardial fibrosis. Magnification bar = 100 μm.
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group, consistent with histological findings of increased
interstitial fibrosis in the remote non-ischemic myocar-
dium in the MI group (Figure 3). Molecular and histo-
logical findings of ventricular remodeling were seen in
non-ischemic myocardium after small MI but without ven-
tricular dilatation (Figure 2A).Echocardiographic and hemodynamic evaluation before
and after dobutamine infusion
At 7 weeks after MI, echocardiography and cardiac
catheterization were performed simultaneously at rest and
with continuous intravenous infusion of dobutamine (first
5 and then 10 μg/kg/min) under ketamine/xylazine
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Figure 4 (See legend on next page.)
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Figure 4 Echocardiographic and hemodynamic changes with dubutamine stimulation after small MI. A: Echocardiographic findings at
7 weeks after MI with dobutamine stimulation (baseline, 5, and 10 μg/kg/min for MI [n = 5] and sham groups [n = 5]) under xylazine/ketamine
anesthesia. Significant heart rate increases were noted in MI group at 10 μg/kg/min, but not in sham group. %FS did not significantly change in
response to dobutamine in either group, although there is a mild dose-dependent positive trend in sham mice. # p < 0.05 vs. baseline.
B: Hemodynamic data by cardiac catheterization at 7 weeks in MI (n = 5) and sham group (n = 5) with dobutamine stimulation (baseline, 5 μg/kg/min,
and 10 μg/kg/min). LVSP was comparable between MI and sham at the baseline but became significantly higher in sham than in MI with maximum
dobutamine stimulation. LVEDP was significantly higher in MI than in sham group at the baseline, and these values did not significantly change with
dobutamine stimulation. Maximum response in (+)dP/dTmax and (−)dP/dTmax by dobutamine infusion from baseline were shown. Even at the baseline,
sham hearts showed better systolic and diastolic LV function than MI hearts. In addition, sham hearts had better response to dobutamine stimulation
for both systolic and diastolic function. * p < 0.05 vs. sham; # p < 0.05 vs. baseline.
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sham group. %FS by echocardiogram showed positive re-
sponse by dobutamine, more in the sham group than in
the MI group, although the increase was not statistically
significant (Figure 4A). In hemodynamic evaluation, LVSP
increased significantly with 10 μg/kg/min of dobutamine
infusion in sham, whereas the increase was only modest in
the MI group (Figure 4B). LVEDP was notably higher in
MI than in sham, but the value did not change throughout
dobutamine stimulation in either group. At the baseline,
the absolute values of both (+)dP/dTmax and (−)dP/dTmax
were significantly higher in the sham group than in the MI
group (6820 ± 573 vs. 4115 ± 485 [p < 0.05], and –6144 ±
614 vs. –3824 ± 540 [p < 0.05], respectively); further diffe-
rence was observed with the 10 μg/kg/min of dobutamine
infusion (15681 ± 2128 vs. 8118 ± 1144 [p < 0.05] and –
11986 ± 1257 vs. –5542 ± 920 [p < 0.05], respectively),
suggesting that both systolic and diastolic ventricular re-
serve capacities were significantly diminished in MI
compared with sham. Three of 5 MI mice developed
hemodynamic instability at 20 μg/kg/min of dobutamine
infusion. Of these 3, 2 mice subsequently died of cardio-
vascular collapse. Echocardiographic measurements at
7 wk were not included in Figure 2 because the method of
anesthesia was different, which caused a significantly
lower heart rate than under isoflurane anesthesia. Never-
theless, the measured echocardiographic parameters at 7
wks for both MI and sham were comparable from those
obtained at 5 wks (data not shown).IWS changes in relation to dobutamine stimulation
IWS changes in both MI and sham groups, before and
after dobutamine stimulation (5 and 10 μg/kg/min), are
shown in Figure 5A. IWS was comparable between the
two groups at the baseline. But with dobutamine stimu-
lation, IWS was significantly increased in MI group,
whereas IWS was relatively unchanged in sham group.
Increased IWS implies increased external ventricular
work load that is not absorbed by the intrinsic myocar-
dial contractile reserve. The difference in myocardial re-
serve capacity in the two groups was reflected in IWS
changes with dobutamine stimulation. Increased IWS bydobutamine stimulation in MI mice indicates increased
ventricular workload in MI mice in a stressed condition.
We also measured peak systolic wall stress (PS-WS)
and end diastolic wall stress (ED-WS) before and after
dobutamine infusion in both groups (Figures 5B and C).
At the resting condition, there was no significant differ-
ence in either PS-WS or ED-WS between MI and sham
groups, although values in MI appear slightly higher
than those of sham. However, with dobutamine stimula-
tion, PS-WS in MI became significantly higher than that
in sham at both 5 and 10 μg/kg/min infusion. This is be-
cause peak-systolic LV cavity size (LVIDs) in MI was
higher than in sham and because peak-systolic LV wall
thickness (LVPWs) in MI was lower than in sham, both
of which contributed to higher PS-WS despite lower
peak systolic LV pressure in MI mice than in sham. On
the other hand, although ED-WS was persistently higher
in MI than in sham, absolute values of ED-WS were far
lower than those of PS-WS in both MI and sham hearts
(approximately 10% of PS-WS). Thus, PS-WS, along
with HR, is a predominant determinant for overall IWS
in this small MI model.Relationship between IWS and the product of PS-WS and
heart rate
Increased IWS in dobutamine-stimulated condition in
the MI group appeared to be primarily related to in-
creased heart rate and higher PS-WS when compared
with the sham group. Thus, we calculated the “IWS
index” by multiplying PS-WS with heart rate as a marker
for IWS, and examined whether IWS correlates well
with calculated IWS index (= PS-WS ×HR). Figure 6
shows that there is a good correlation between PS-WS ×
HR and IWS, both in sham-operated and MI hearts (y =
0.0191 x – 2155.4, R = 0.7003).Discussion
IWS measures total wall stress throughout the cardiac
cycle over a unit time (= 1 min) including the effect of
heart rate and inotropic state of the ventricular myocar-
dium, whereas one-spot measurement of PS-WS and
ED-WS only reflects maximum and minimum wall stress
Figure 6 Correlation between IWS and “IWS index (= PS-WS ×
HR)”. There is an excellent correlation between IWS and peak
systolic WS (PS-WS) × HR.
A
B C
Figure 5 Changes in IWS, peak systolic WS, and end diastolic WS with dobutamine stimulation. A: IWS changes with incremental dobutamine
stress. The IWS were comparable between MI (n = 5) and sham group (n = 5) at the baseline. However, IWS in MI hearts increased significantly with
dobutamine stimulation, whereas there was no noticeable increase of IWS in the sham hearts. ms: millisecond. Changes in peak systolic WS (B) and
end diastolic WS (C) with incremental dobutamine stress after small MI. Both peak systolic WS and end diastolic WS in MI hearts were significantly
higher than those in sham hearts with dobutamine stimulation. * p < 0.05 vs. sham, # p < 0.05 vs. 0 mcg/kg/min, § < 0.05 vs. 5 mcg/kg/min.
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increase in IWS indicates failure of myocardium to coun-
teract increased ventricular workload. We have measured
IWS in the mouse model in various physiological and
pathological conditions to validate this hypothesis. Un-
changed IWS observed in sham operated mice may imply
that the contractile reserve of ventricular myocardium can
absorb the increased cardiac output, whereas increased
IWS after MI suggests that ventricular workloads exceeds
intrinsic myocardial contractile reserve. Thus, we postu-
late that IWS is a reliable physiological marker in indicat-
ing a balance between external ventricular workload and
intrinsic myocardial contractile reserve.
IWS and myocardial reserve
“Wall stress theory” is an important concept in under-
standing the process of cardiac hypertrophy in response to
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cardium encounters biomechanical overload, either pres-
sure overload or volume overload, cardiac hypertrophy is
naturally induced to normalize the wall stress so that myo-
cardium can minimize the increase in myocardial oxygen
demand; myocardial oxygen consumption depends mainly
on systolic wall stress, heart rate, and contractility [8,17]. A
question arises whether this hypertrophic response is a com-
pensatory physiological adaptation to stabilize the wall stress
or a pathological process leading to ventricular remodeling
and heart failure. Physiological hypertrophy as seen in
trained athletes reveals increased contractile reserve,
whereas pathological hypertrophy shows a decrease in con-
tractile reserve in addition to molecular expression of ven-
tricular remodeling [18-20]. However, what regulates the
transition from compensatory adaptation to maladaptive
process is not well understood.
Systolic wall stress has been studied extensively as a
clinical marker for myocardial reserve. Systolic wall stress
reflects the major determinants of the degree of LV hyper-
trophy and plays a predominant role in LV function and
myocardial energy balance [17]. It has been shown that in-
creased systolic wall stress inversely correlates with sys-
tolic function and myocardial reserve in patients with
chronic volume overload [9,10,21], chronic pressure over-
load [22,23], and dilated cardiomyopathy [24]. However,
one-point measurement of systolic wall stress does not en-
compass the effect of heart rate and contractile status, the
other critical factors that affect myocardial oxygen de-
mand [11]. The idea of IWS has been proposed to incorp-
orate wall stress throughout the cardiac cycle and reflects
the effects of heart rate and contractile status.
Myocardial oxygen consumption is determined mainly
by ventricular wall stress, heart rate and contractility
[17], which are all incorporated in IWS measurement.
Continuous measurement of LV wall stress was previ-
ously reported in humans [12,15] and dogs [11] with a
similar method, but not in mice. By integrating the con-
tinuous WS over one minute, we estimated the balance
between myocardial contractile reserve and total exter-
nal ventricular workload and examined its trend in rela-
tion to inotropic stimulation in the mouse heart in vivo.
In this study, we have proposed unchanged IWS as a
marker of sufficient myocardial contractile reserve, since
increased wall stress demands higher myocardial oxygen
consumption. Indeed, systolic wall stress does not in-
crease with strenuous isometric exercise in healthy
young athletes [25]. Thus, we propose that increase in
IWS indicates diminished myocardial contractile reserve.
Small MI model as a unique model to study early phase
of progressive ventricular remodeling
A complex series of protective and damaging events
takes place after MI, resulting in increased ventricularworkload [26]. Initial ventricular geometric change is
considered as a primary compensatory response to coun-
teract an abrupt loss of contractile tissue. In classical the-
ories of wall stress, which rely on the law of Laplace,
the mechanisms of progressive ventricular dilatation
and functional deterioration of the LV are attributed to
the increased wall stress that is not compensated by
the intrinsic compensatory mechanisms [2,16]. Although
this theory is obvious in advanced stage of heart failure,
the subclinical ventricular remodeling following border-
line cases such as following small MI with initial full com-
pensatory response is not well explained.
We have shown that our small MI model induced con-
centric hypertrophy without LV dilatation as if initial myo-
cardial damage was completely compensated (Figure 2) [5].
Although LV hypertrophy is induced initially to normalize
the wall stress and to prevent ventricular dilatation, this
hypertrophy is not altogether a physiological one because
of decreased inotrophic and lusitropic reserve when stimu-
lated with dobutamine (Figure 4) and because of simultan-
eous molecular and histological evidence of remodeling in
the remote nonischemic LV myocardium (Figure 3). IWS
and PS-WS become normalized in small MI at rest under
anesthesia as a result of reactive hypertrophy accompanied
by increased ANP and BNP mRNA level. Borderline mal-
adaptive LVH is characterized by maintained LV perform-
ance at the expense of limited myocardial contractile
reserve, and this abnormality can be unmasked by ino-
tropic stimulation [18]. The trend of IWS at rest and with
dobutamine stimulation suggests that MI mice were likely
exposed to higher IWS during usual awake and active con-
dition than sham-operated mice. In contrast, systolic wall
stress in the pressure overload-induced LV hypertrophy
showed a level comparable to that of sham both at rest and
under stimulation by β1 adrenergic agonist, prenalterol,
with comparable heart rate changes [27]. For this reason,
IWS assessment by measuring cumulative WS in a unit
time with and without inotropic stimuation should serve
as a sensitive marker to assess whether induced LV hyper-
trophy is a compensatory physiological adaptation process
or a pathological maladaptation process. Increased IWS
that indicates imposed workload surpassing myocardial
contractile reserve is likely to become a major driving fac-
tor in inducing progressive ventricular remodeling or initi-
ating deleterious maladaptive processes after MI.
IWS represents myocardial oxygen demand that can be
estimated non-invasively
We have demonstrated a very good correlation between
IWS and the product of PS-WS and HR (“IWS index”)
in both MI and sham-operated hearts (Figure 6). This
formula appears physiologically acceptable provided that
ED-WS is sufficiently low compared with the PS-WS
(approximately 10%, as is shown in Figures 4B and C).
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assessing myocardial loading status and myocardial oxy-
gen consumption, but its measurement requires compli-
cated preparation [28,29]. Because there is an excellent
correlation between PS-WS and ES-WS, it has been
demonstrated that ES-WS can be substituted by PS-WS
[28], which can be easily obtained non-invasively [30].
ES-WS was previously determined as a useful marker to
quantify LV afterload and contractility that can be simply
and accurately measured non-invasively [15]. As myo-
cardial oxygen consumption is mainly dependent upon
systolic wall stress, contractility, and heart rate, it seems
reasonable to propose that IWS and IWS index repre-
sent the status of myocardial contractile reserve.
Study limitations
There are certain limitations in this study. First, wall
stress measurement is reliable when there is an equal
wall thickness with symmetrical structure. Obviously,
with the creation of small MI, there is an asymmetry of
LV myocardium in both structure and consistency (myo-
cardium vs. scar tissue). However, the scar tissue is small
and restricted to the LV apex (approximately 14% of en-
tire LV myocardium [5]). In fact, most of LV wall was
thickened after induction of this small experimental MI.
Nevertheless, we acknowledge that this is our major
limitation. Secondly, there is an individual variability in
response to dobutamine stimulation even in sham mice.
Although the average sham mice (n = 5) showed only a
modest increase in HR, PS-WS, and IWS during
dobutamine stimulation, one mouse presented in Figure 1
showed a notable increase in HR and PS-WS in response
to dobutamine. Nevertheless, even with increased HR and
PS-WS, the calculated IWS remained relatively un-
changed in the sham-operated mice. Lastly, the reliability
of IWS index is based upon the stipulation that ED-WS is
significantly low compared with the systolic wall stress.
Thus, IWS index may not be accurate in obvious volume
overload cases and/or dilated hearts with LV dysfunction
where ED-WS is significantly higher than that in normal
condition. Of note, ED-WS in human is higher than that
in mice in relation to PS-WS, probably around 15 to 20%
of PS-WS [12].
Clinical implications
IWS can be estimated by obtaining IWS index, which is
calculated non-invasively by simultaneous M-mode
echocardiogram and cuff blood pressure measurement,
i.e., PS-WS instead of ES-WS and heart rate. This will
provide a sensitive way to detect subclinical borderline
failing myocardium in which the decline in LV myocar-
dial contractile reserve precedes apparent LV dysfunc-
tion. This method may be clinically useful to address
LV myocardial reserve in those patients who are notamenable to perform on exercise stress test, such as
immediate post-operative patients under mechanical venti-
lation, critically ill patients with questionable LV dysfunction,
and patients with primary muscular disorders and general
muscular weakness (i.e., Duchenne muscular dystrophy).
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